Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole

J Med Vet Mycol. 1995 Jul-Aug;33(4):267-70. doi: 10.1080/02681219580000531.

Abstract

A case of Rhodotorula minuta central venous catheter infection with fungaemia is described in a patient with advanced acquired immunodeficiency syndrome (AIDS), HIV nephropathy, end-stage renal disease requiring haemodialysis, and a permanent Quinton catheter in place for 6 months. At the time of fungaemia, the patient was taking 100 mg fluconazole per os daily for a previous episode of Candida oesophagitis. R. minuta central venous catheter infection with fungaemia was successfully treated with 455 mg total dose amphotericin B (0.6 mg kg-1 day-1) over 25 days without removal of the catheter. In vitro antifungal susceptibility testing for R. minuta revealed a minimum inhibitory concentration to fluconazole of > 100 micrograms ml-1 and to amphotericin B of 1.2 microgram ml-1. Clinically evident fungaemia, even with an unusual organism such as R. minuta, may occur in patients with intravenous catheters, and while the immunosuppressed patient is receiving azole therapy.

Publication types

  • Case Reports
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology*
  • AIDS-Related Opportunistic Infections / prevention & control
  • Adult
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Candidiasis / prevention & control
  • Catheterization, Central Venous*
  • Esophageal Diseases / microbiology
  • Esophageal Diseases / prevention & control
  • Fluconazole / therapeutic use*
  • Fungemia / drug therapy
  • Fungemia / etiology*
  • HIV Seropositivity
  • Humans
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / therapy
  • Male
  • Renal Dialysis
  • Rhodotorula* / isolation & purification

Substances

  • Antifungal Agents
  • Amphotericin B
  • Fluconazole